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Abstract
Background: Assessment of hemoglobin is one of the most reliable indicators for anemia, and is widely used to
screen for anemia among pregnant women. The HemoCue
® has been widely used for as a point-of-care device for
hemoglobin estimation in health facilities. Previous studies showed contradictory results regarding the accuracy of
HemoCue
®.
Methods: This was a hospital-based cross sectional study carried- out among pregnant women at Khartoum
hospital in Sudan to find out whether the measurement of hemoglobin concentration by HemoCue
® using venous
or capillary samples was comparable to that of the automated hematology analyzer as standard. Bland and Altman
method was used to compare the measurements with an acceptable difference of ± 1.0 g/dl.
Results: Among the 108 subjects in this study the mean (SD) level of hemoglobin level using HemoCue
® venous
sample, HemoCue
® capillary sample and automated hematology analyzer were 12.70 (1.77), 12.87 (2.04) and 11.53
(1.63) g/dl, respectively. Although the correlations between the measurements were all significant there was no
agreement between HemoCue
® and automated hematology analyzer. The bias + SD (limits of agreement) for
HemoCue
® venous versus hematology analyzer was 1.17 ± 1.57 (-1.97, 4.31) g/dl, HemoCue
® capillary versus
hematology analyzer was 1.34 ± 1.85 (-2.36, 5.04) g/dl, and HemoCue
® venous versus HemoCue
® capillary samples
was 017 ± 1.90 and (3.97-3.63) g/dl.
Conclusion: Hemoglobin concentration assessment by HemoCue
® using either venous or capillary blood samples
has shown unacceptable agreement with automated hematology analyzer.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/8797022296725036
Introduction
Anemia is one of the most important causes of morbid-
ity and mortality in developing countries, especially
among pregnant women [1]. The world prevalence of
anemia in pregnant women and non-pregnant women is
41.8% and 30.2% respectively [2]. Pregnant Sudanese
women are susceptible to anemia regardless to their age
and parity and anemia is one of the leading causes of
maternal and perinatal morbidity and mortality [3-5].
Assessment of hemoglobin is one of the most reliable
indicators for anemia, and is widely used to screen for
anemic individuals, and to evaluate responses to inter-
ventions [6]. Hemoglobin concentration is routinely
measured using automated hematology analyzers.
Although, these are very accurate and reliable, they are
expensive and problems of samples transport to the
laboratory may delay treatment resulting in preventable
deaths [7]. In poor resources where automated hematol-
ogy analyzer is not available other methods of low price
and that require less skill are highly needed. Although
Cyanmethemoglobin method is cheaper and often used, * Correspondence: ishagadam@hotmail.com
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copper sulfate method which is used in blood donation
is very easy and inexpensive; it does not provide an
acceptable degree of accuracy.
The HemoCue
® hemoglobin photometer has been
widely used for as a point-of-care device for hemoglobin
estimation in mobile blood donations and critical care
areas in health facilities [8]. Previous studies showed
contradictory results regarding the accuracy of Hemo-
Cue
®; some of research reported a high accuracy of
HemoCue
® compared with standard laboratory methods
[9,10]. However, others did not recommend this device
in general practice [11-13]. Few published data exist on
the accuracy of HemoCue
® in the measurement of
hemoglobin during pregnancy [14,15]. The aim of this
study was to compare the accuracy of HemoCue
® using
venous and capillary samples with that of the automated
hematology analyzer in the measurement of hemoglobin
among pregnant Sudanese women at Khartoum
Hospital.
Material and methods
This was a cross sectional study carried- out among
pregnant women at Khartoum hospital in Sudan during
the period of October through December 2011. Conve-
nient sampling method was used in the study in which
all available subjects who fulfilled the inclusion criteria
at the Khartoum hospital antenatal care clinic were
recruited in the study every day until total number of
s a m p l es i z ew a sa c h i e v e d .S a m p l es i z eo f1 0 8s u b j e c t s
was calculated based on a 2-sided hypothesis tests using
Epiinfo with 80% power and confidence interval of 95%.
After signing an informed consent venous and capillary
blood samples were taken from each woman to be mea-
sured by HemoCue
® (venous and capillary) and the
automated analyzer.
Capillary blood samples were collected by finger prick
in the middle finger of left hand, after cleaning and mas-
saging the finger to facilitate blood flow. Venous blood
samples were collected into vacutainer tubes and were
analyzed immediately by HemoCue
® and the tubes were
sent to the medical laboratory of the hospital for the




® B-Hemoglobin system (HemoCue
® AB,
Ängelholm, Sweden) consistso fd i s p o s a b l em i c r o c u v -
ettes containing reagent in a dry form and a single pur-
pose designed photometer. The microcuvettes were
s t o r e di nad r yp l a c ea tr o o mt e m p e r a t u r e .O n c e
opened, they were tightly closed and stored at the same
conditions to maintain their integrity and shelf life. The
reaction in the microcuvette is a modified azide-methe-
moglobin reaction. Sodium deoxycholate haemolyses
erythrocytes and hemoglobin is released. Sodium nitrite
converts hemoglobin to methemoglobin which, together
with sodium azide, gives azidemethemoglobin. The
absorbance is measured at two wavelengths (570 nm
and 880 nm) in order to compensate for turbidity in the
sample. The test was performed as stated by the manu-
facturer [16].
Automated hematology analyzer
The Sysmex KX21N (Sysmex Corporation, Kobe, Japan)
is an automated blood cell counter intended for in vitro
diagnostic use in clinical laboratories. It is a compact,
fully automated hematology analyzer with simultaneous
analysis of 18 parameters in whole blood mode and
capillary blood mode. It measures the hemoglobin con-
centration using a non-cyanide hemoglobin method
(STROMATOLYSER WH). The instrument has been
proven to provide accurate and reliable results including
hemoglobin concentrations [17,18]. The test was per-
formed as stated in the manufacturer’s manual [19].
Quality control
The HemoCue
® photometer was checked on a daily
basis using the control cuvette and a standard of known
concentration. A three set controls were run daily to
ensure the function of the Sysmex.
Statistics
All statistical analyses were performed using SPSS soft-
ware (SPSS Inc., Chicago, IL, USA, version 16.0). Hemo-
globin levels were measured using two instruments;
HemoCue
® and automated hematology analyzer. Hemo-
Cue
® used two types of samples; venous as well as capil-
lary samples. Pairs of hemoglobin measurements were
compared as follows: HemoCue
® venous sample versus
automated hematology analyzer, HemoCue
® capillary
sample versus automated hematology analyzer, Hemo-
Cue
® venous sample versus HemoCue
® capillary sam-
ple. Pearson Correlation analysis was performed and
correlation coefficient (r) was calculated. The Mean of
differences (bias), standard deviation of differences (SD),
and limits of agreement (Mean ± 2 × SD) were calcu-
lated according to the Bland and Altman method [20].
Limits of agreement not exceeding ±1 g/dl between any
two pairs of methods were considered to be clinically
acceptable.
Ethics
This study was completely conducted voluntarily and all
respondents were given brief explanations about the
purpose and procedures of the study to be used. Volun-
tarily consent was signed by each subject before taking
the blood. Ethical clearance was obtained from the insti-
tute Board.
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A total number of 108 pregnant women were recruited
in this study. Their mean (SD) of the age and gestational
age were 27.6 (6.8) years and 24.9 (10.2) weeks.
The mean (SD) hemoglobin level was 12.70 (1.77),
12.87 (2.04) and 11.53 (1.63) g/dl using HemoCue
®
venous sample, HemoCue
® capillary sample and auto-
mated hematology analyzer, respectively (Table 1).
HemoCue
® venous versus automated hematology
analyzer
There was a positive correlation (r =0 . 5 8 ,P <0 . 0 0 1 )
between hemoglobin levels by using HemoCue
® venous
sample versus automated hematology analyzer. The mean
difference with limits of agreement between the two read-
ing was 1.17 (-1.97, 4.31) g/dl (Table 2 and Figure 1).
HemoCue
® capillary versus automated hematology
analyzer
There was a positive correlation between hemoglobin
levels by using HemoCue
® capillary sample versus auto-
mated hematology analyzer (r =0 . 5 1 ,P < 0.001). The
mean difference with limits of agreement between
hemoglobin levels by using HemoCue
® capillary sample
versus automated hematology analyzer was 1.34 (-2.36,
5.04) g/dl (Table 2 and Figure 2).
HemoCue
® venous versus HemoCue
® capillary sample
There were positive correlation between hemoglobin
levels by using HemoCue
® venous sample versus Hemo-
Cue
® capillary sample (r =0 . 5 1 ,P < 0.001). The mean
difference with limits of agreement between hemoglobin
levels by using HemoCue
® venous sample versus Hemo-
Cue
® capillary sample was -0.17 (-3.97, 3.63) g/dl (Table
2 and Figure 3).
According to the previously pre-defined clinical accep-




® portable hemoglobin photometer
using venous or capillary blood samples has been widely
used for quick assessment of hemoglobin concentra-
tions; especially in poor settings where skills and
resources are limited.
The accuracy of HemoCue
® for measuring hemoglo-
bin in clinical settings is still a matter of controversy.
The results of this study have shown that the hemoglo-
bin concentration of HemoCue
® using either venous or
capillary blood samples have lower level of precision
and was not comparable with that of automated hema-
tology analyzer; the limits of agreement were larger than
the predefined clinically acceptable limits of ±1 g/dl.
This is goes with the previous findings of the studies
conducted among pregnant women at high altitude [14]
and adult patients hospitalized in surgical intensive care
unit [21]. The difference between the readings has been
explained by the use of only one microcuvette with
HemoCue
® especially when using capillary blood sam-
ples and laboratory values, and advised loading multiple
microcuvettes and averaging the hemoglobin values
obtained has been proposed [22].
However, other studies showed that the results
obtained by using HemoCue
® for hemoglobin assess-
ment among pregnant women were comparable to that
of automated hematology analyzer as a standard [9].
Bernard et al., found that the results of hemoglobin
concentration among pregnant and non-pregnant popu-
lations using HemoCue
® were comparable to that of
automated hematology analyzer and Cyanmethemoglo-
bin methods [23]. Other studies which were conducted
in different settings and populations such as patients
with gastrointestinal bleeding, surgical patients repeated
measurement of one sample, urban general practice,
neonates, patients undergoing aortic surgery in the thea-
tre and blood donors recommended HemoCue
® for the
hemoglobin estimation [8,24-31]. Paiva et al. found that
HemoCue
® was more appropriate for capillary com-
pared to venous blood samples [32]. However, there was
within-subject variability of capillary blood hemoglobin
values that might explain the unreliability of the
Table 1 Hemoglobin level measured using HemoCue
®
venous sample, HemoCue
® capillary sample, and
automated hematology analyzer (g/dl)
Method of measurement Mean ± SD Median (min; max)
HemoCue
® (venous) 12.70 ± 1.77 12.80 (8.90; 17.90)
HemoCue
® (capillary) 12.87 ± 2.04 12.90 (8.20; 17.70)
Hematology analyzer 11.53 ± 1.63 11.40 (8.10; 15.00)
Table 2 Correlation, bias, and limits of agreement between hemoglobin level using HemoCue
® and automated
hematology analyzer
Comparison of methods Correlation Coefficient Bias ± SD (95%CI) Limits of agreement
HemoCue
® (venous) vs. Hematology analyzer 0.58 1.17 ± 1.57 (0.87; 1.47) -1.97 to 4.31
HemoCue
® (capillary) vs. Hematology analyzer 0.51 1.34 ± 1.85 (0.99; 1.69) -2.36 to 5.04
HemoCue
® (venous) vs. HemoCue
® (capillary) 0.51 -0.17 ± 1.90 (-0.53; 0.19) -3.97 to 3.63
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® venous sample versus automated hematology analyzer (g/dl).
Figure 2 Bland and Altman plot for hemoglobin level by using HemoCue
® capillary sample versus automated hematology analyzer (g/dl).
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ples taken from different fingers of the same subjects
had hemoglobin concentrations differing by/ more than
two g/dL using the HemoCue
® [6].
In spite of the non-acceptable agreement of Hemo-
Cue
® with automated hematology analyzer in this study,
the HemoCue
® is however simple to use, need mini-
mum training, cheap, and gives an immediate result.
Furthermore, it is useful in clinical and epidemiological
settings where finger puncture allows capillary blood
sampling as an easy technique which is less resource-
intensive than vein puncture, and is more acceptable to
patients and the community.
Conclusion
Hemoglobin concentration assessment by HemoCue
®
using either venous or capillary blood samples does not
have an acceptable agreement with automated hematol-
ogy analyzer. Therefore this study does not recommend
this device for hemoglobin concentration assessment
among pregnant women.
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